Carolyn Ritterson Lew

Carolyn Ritterson Lew, Ph.D. has a diverse work experience spanning several years. Carolyn currently holds the role of Lead Research Analyst at Merative since 2022. Prior to this, they worked at IBM, where they served as a Lead Research Analyst from 2020 to 2022 and as a Senior Research Analyst from 2020 to 2022. Before joining IBM, Dr. Lew was a Research Analyst I at Truven Health Analytics®, part of the IBM Watson Health™ business, from 2017 to 2020. Carolyn also gained experience as a Science Analyst at Forte Information Resources from 2017 to 2017 and as a Technical Writer from 2016 to 2017. As a Postdoctoral Fellow at the University of Colorado, they worked from 2012 to 2016. Dr. Lew obtained their Ph.D. in Molecular and Cell Biology and Biochemistry from Boston University, where their Ph.D. thesis focused on "Non-glycolytic Roles for Aldolase in Actin-Dependent Cellular Processes," during their tenure from 2004 to 2011. Carolyn began their career with a Research Internship at A.I. duPont Hospital for Children in 2003.

Dr. Carolyn Ritterson Lew obtained their Bachelor of Science degree in Cell Biology/Biochemistry from Bucknell University, where they studied from 2000 to 2004. Carolyn then pursued a Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology at Boston University, completing their studies from 2004 to 2011.